Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:43:00 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



Q:TBPH - THERAVANCE BIOPHARMA INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TBPH - Q8.09.45·10.691.99.46    11.98  8.21May 03Apr 2915 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-29 06:00U:TBPHNews ReleaseTheravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
2024-04-10 06:00U:TBPHNews ReleaseTheravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
2024-02-26 16:05U:TBPHNews ReleaseTheravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2024-02-22 06:00U:TBPHNews ReleaseTheravance Biopharma to Participate in an Upcoming Investor Conference
2024-02-14 06:00U:TBPHNews ReleaseTheravance Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
2024-01-05 06:00U:TBPHNews ReleaseTheravance Biopharma Announces Results from the Phase 4 YUPELRI ‚ ® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
2023-12-21 17:00U:TBPHNews ReleaseTheravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors
2023-12-18 06:00U:TBPHNews ReleaseTheravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference
2023-11-16 06:00U:TBPHNews ReleaseTheravance Biopharma to Present New Ampreloxetine Data at the 34th International Symposium on The Autonomic Nervous System
2023-11-15 06:00U:TBPHNews ReleaseTheravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx Conference
2023-11-13 08:00U:TBPHNews ReleaseViatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI ‚ ® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
2023-11-07 16:28U:TBPHNews ReleaseTheravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
2023-10-19 06:00U:TBPHNews ReleaseTheravance Biopharma to Report Third Quarter 2023 Financial Results on November 7, 2023
2023-08-29 06:00U:TBPHNews ReleaseTheravance Biopharma to Participate in an Upcoming Investor Conference
2023-08-28 06:23U:TBPHNews ReleaseTheravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson's Disease and Movement Disorders
2023-08-07 16:05U:TBPHNews ReleaseTheravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
2023-07-24 06:00U:TBPHNews ReleaseTheravance Biopharma to Report Second Quarter 2023 Financial Results on August 7, 2023